Soleus Capital Management »

Hims & Hers Heal shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Hims & Hers Heal (HIMS) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Hims & Hers Heal

Tip: Access up to 7 years of quarterly data

All positions including Hims & Hers Heal held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hims & Hers Heal by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.7M 333k 20.19

More positions owned by Soleus Capital Management

Spdr Ser Tr S&p Biotech Call Option (XBI)
Iovance Biotherapeutics (IOVA)
Tg Therapeutics (TGTX)
Terns Pharmaceuticals (TERN)
Axogen (AXGN)
Grifols S A Sp Adr Rep B Nvt (GRFS)
Krystal Biotech (KRYS)
C4 Therapeutics Com Stk (CCCC)
United Therapeutics Corporation (UTHR)
Sanofi Sponsored Adr (SNY)
Organogenesis Hldgs (ORGO)
Ideaya Biosciences (IDYA)
Revolution Medicines (RVMD)
Quidel Corp (QDEL)
Essa Pharma Com New (EPIX)

View all positions for Soleus Capital Management

Top funds holding Hims & Hers Heal

Vanguard Group
BlackRock
Renaissance Technologies
State Street Corporation
Institutional Venture Management XVI
Geode Capital Management
Citadel Advisors
Susquehanna International
Wellington Management Company
Nuveen Asset Management
Dimensional Fund Advisors
Institutional Venture Management XV
Qube Research & Technologies
Divisadero Street Capital Management
Arrowstreet Capital, Limited Partnership

View all funds holding Hims & Hers Heal